Related Experiment Video
Updated: May 28, 2025
Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Plasma Proteins Predict Kidney Function Trajectories in Type 2 Diabetes
Resham L Gurung1,2, Huili Zheng1, Jia Le Ivan Tan1
1Clinical Research Unit, Khoo Teck Puat Hospital, Singapore 768828, Singapore.
Objective:
The rate of decline in estimated glomerular filtration rate (eGFR) varies among patients with type 2 diabetes (T2D). We aimed to identify plasma proteins associated with diverse eGFR trajectories in T2D.
Methods:
We performed latent class mixed models analysis among patients with T2D and relatively preserved kidney function (baseline eGFR ≥60 mL/min/1.73 m2) from the Singapore Study of Macro-angiopathy and Micro-Vascular Reactivity in Type 2 Diabetes (SMART2D) (n = 1285) and diabetic nephropathy (n = 798) cohorts to identify patterns of eGFR trajectories. Comprehensive proteomic association with eGFR trajectories was assessed using multivariable logistic regression in the SMART2D cohort.
Results:
Three distinct eGFR trajectories groups-slow decline (92.2%), progressive decline (4.0%), and accelerated decline (3.8%)-were identified in SMART2D and validated in the diabetic nephropathy cohort. Participants in the accelerated decline group exhibited the highest risk of progression to end-stage kidney disease (log-rank test, P < .0001). Among 1448 proteins analyzed in the SMART2D cohort, 19 proteins, including KIM-1 (odds ratio [OR] = 2.95; 95% CI, 2.01-4.32; P = 2.95 × 10-8), MMP7 (OR = 16.5; 95% CI, 5.54-49.07; P = 4.61 × 10-7), and VSIG4 (OR = 7.38; 95% CI, 3.22-16.89; P = 2.24 × 10-6), were associated with accelerated decline and 1 protein (OR = 6.34; 95% CI, 2.77-14.52; P = 1.26 × 10-5) was associated with progressive decline, independent of traditional cardiorenal risk factors including baseline kidney function. Adding these proteins to clinical risk factors (age, sex, ethnicity, eGFR, urine albumin-to-creatinine ratio, HbA1c, diabetes duration, systolic blood pressure, triglyceride) improved area under the curve to 0.77 (delta 0.04, P = .057) for progressive decline and 0.93 (delta 0.09, P < .001) for accelerated decline.
Conclusion:
Different plasma proteins are associated with progressive and accelerated eGFR decline, independent of traditional cardiorenal risk factors, some of which enhance eGFR trajectory prediction in patients with T2D.
Related Concept Videos
01:17Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
01:20Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
01:10Nephrons
01:28Glomerular Filtration Rate and its Regulation
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
01:27Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
01:11Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...